Skip to main content

Sichuan Kelun Pharmaceutical Co Ltd Assigned Short-Term Ba3 & Long-Term Ba3 Credit Rating

In this scenario, we would still include the existing debt maturity as a use of liquidity in our A/B and A-B calculations, if the debt matures within the corresponding liquidity horizon. The rationale is that our liquidity assessment is essentially a stress test against a sudden and severe loss of capital markets access availability. For companies with an anchor of at least 'bbb-' that meet certain characteristics, as outlined in paragraphs 38 and 39 of the criteria, we may use a shorter three- to six-month time horizon when assessing upcoming maturities.Sichuan Kelun Pharmaceutical Co Ltd Assigned Short-Term Ba3 & Long-Term Ba3 Credit Rating. How Does Credit Rating Model Work?

Rating Model for Sichuan Kelun Pharmaceutical Co Ltd: We estimate the credit risk parameters by RRS and Multiple Regression

Credit Ratings for Sichuan Kelun Pharmaceutical Co Ltd as of 29 Mar 2022


Credit Rating Short-Term Long-Term Senior
AI Rating Class*Ba3Ba3
Semantic Signals6476
Financial Signals5967
Risk Signals8649
Substantial Risks7645
Speculative Signals3576

*Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines.Take a look at: How Does Credit Rating Model Work?

Financial Analysis for Sichuan Kelun Pharmaceutical Co Ltd


Financials: PREMIUM
Income Statement: PREMIUM
Balance Sheet: PREMIUM
Cash Flow: PREMIUM
Valuation: PREMIUM
Inventory Valuation: PREMIUM
Dividends: PREMIUM
Operating Performance: PREMIUM
Sustainability: PREMIUM
Price vs. Fair Value: PREMIUM
Stock Analysis: PREMIUM

Analyst Rating for Sichuan Kelun Pharmaceutical Co Ltd


Is it the right time to buy or sell? : PREMIUM
Fair Value : PREMIUM
Trailing Returns : PREMIUM

Key Statistics for Sichuan Kelun Pharmaceutical Co Ltd


Price/Book : PREMIUM
Price/Cash Flow : PREMIUM
Price/Sales : PREMIUM
Price/Earnings : PREMIUM
Operating Income : PREMIUM
Net Income : PREMIUM
Quick Ratio : PREMIUM
Current Ratio : PREMIUM
Interest Coverage : PREMIUM
Debt/Equity : PREMIUM
Return on Assets : PREMIUM
Return on Equity : PREMIUM
Invested Capital : PREMIUM
Net Margin : PREMIUM
EBITDA Margin : PREMIUM
Days Sales Outstanding : PREMIUM
Payables Period : PREMIUM
Cash Conversion Cycle : PREMIUM
Recieveables Turnover : PREMIUM
Inventory Turnover : PREMIUM
Fixed Assets Turnover : PREMIUM
Asset Turnover : PREMIUM
Operating Cash Flow Growth : PREMIUM
Free Cash Flow Growth : PREMIUM
Free Cash Flow/Sales : PREMIUM
Free Cash Flow/Net Income : PREMIUM
Free Cash Flow/Share : PREMIUM

Credit Report for Sichuan Kelun Pharmaceutical Co Ltd


Risk Report : PREMIUM
Credit Report : PREMIUM
Commercial Credit Report : PREMIUM

Audit Reports & Filings for Sichuan Kelun Pharmaceutical Co Ltd


Audit Reports : PREMIUM
Principal Risk and Viability : PREMIUM
Risk Analysis : PREMIUM
Retail Technology Environment, Including IT Security : PREMIUM
SEC Filings : PREMIUM
Bankruptcy Filings : PREMIUM
Suit & Judgment Filings : PREMIUM
Tax Lien Filings : PREMIUM

Market Research for Sichuan Kelun Pharmaceutical Co Ltd


Customer Reviews : 12167 reviews PREMIUM
Interviews : PREMIUM
Focus Groups : PREMIUM
Market Share Analysis : PREMIUM


 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |